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Abstract
Background: The diagnosis of left ventricular hypertrophy (LVH) in the presence of the left
bundle branch block (LBBB) is difficult. In our study we compared commonly used ECG
criteria with left ventricular mass index (LVMI) calculated during cardiac magnetic resonance
imaging (CMRI) to verify their clinical value or the need to recalibrate.
Methods: CMRI and ECG data of 36 patients were included in this study. Based on the ECG
measures we used in our study selected ECG criteria for LVH detection in cases with LBBB:
QRS duration, amplitude of S waves in V1, V2, V3; R waves in aVL, V5, V6 and combinations
of amplitudes. LVH was defined as LVMI (CMRI) exceeding reference values.
Results: LVH was diagnosed in 17 (47%) patients (6 women and 11 men). Following ECG
parameters correlated the most prominently with LVMI — RV5: r = 0.5 (p = 0.002), RV6:
r = 0.61 (p = 0.0001), SV1+RV5, 6: r = 0.64 (p = 0.001), RaVL+SV3: r = 0.5 (p = 0.002),
SV2+RV5, 6: r = 0.71 (p = 0.0001), SV2, 3+RV5, 6: r = 0.75 (p = 0.0001). Based on the results
of ROC analysis we proposed new cut points for LVH parameters. The highest diagnostic accuracy
achieved S2+SV3 > 6 mV, SV2,V3+RV5,V6 > 4 mV, RaVL+SV3 > 3.5 mV (86–89%).
Conclusions: In patients with LBBB the ECG parameters based on the amplitude of S wave
in V2 or V3 and R wave in the leads aVL, V5, V6 have the highest clinical value in the pre-
diction of the LVH determined by CMRI. It was necessary to recalibrate these parameters and
it is needed to verify them in larger number of LBBB patients. (Cardiol J 2012; 19, 6: 591–596)
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Introduction
The diagnosis of left ventricular hypertrophy
(LVH) in the presence of the left bundle branch
block (LBBB) is difficult or even in opinion of some
authors impossible [1]. Abnormal ventricular con-
duction usually changes (in either direction) the
QRS amplitude [1]. Classical parameters that are
used for QRS < 120 ms are generally not suitable.
We also know that the important percentage of pa-
tients with LBBB have hypertrophied or dilated
hearts [2]. Cardiac magnetic resonance imaging
(CMRI) is currently used as a gold standard tech-
nique for LV size measurements [3]. It is more pre-
cise in LV measurements than echo [4–6]. To our
knowledge ECG criteria for LVH diagnosis in pa-
tients with LBBB have not been verified with CMRI
results. In our study we compared commonly used
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ECG criteria with left ventricular mass index
(LVMI) calculated during CMRI to verify their clini-
cal value or the need to update.
Methods
From the patients that had CMRI of the heart in
Institute of Cardiology during 2009 and till 30.08.2010
we selected cases with LBBB in the ECG. The ex-
amined group finally consisted of 36 adults, mean age
56 (33–80) years, 21 males and 15 females. Fifteen
patients had dilated cardiomyopathy, 9 ischemic car-
diomyopathy, 4 hypertrophic cardiomyopathy and in
8 patients other pathology was diagnosed.
The study was approved by the local bioethi-
cal committee.
Electrocardiography
All of the ECG were recorded digitally with
Spacelabs Syphonet/Sentinel workstations. ECG
waves and intervals (amplitude and duration) were
measured by one observer (D.P.) using digital cali-
pers and verified by the other (R.B.). LBBB was di-
agnosed using the most recent published criteria [7]:
— QRS duration ≥ 120 ms;
— board, notched or slurred R wave in leads I,
aVL, V5 and V6;
— absent q waves in leads I, V5, V6;
— R peak time > 60 ms in leads V5 and V6 but
normal in V1, V2, V3;
— ST and T waves usually opposite in direction
to QRS.
The separation between LBBB and QRS pro-
longation due to LVH is a well known problem in
electrocardiology. For this reason we include the
cases with QRS > 130 ms.
In our study, we used the following ECG mea-
surements: QRS duration (max in 12 leads), P wave
duration in lead II (in patients with sinus rhythm),
R wave amplitude in leads I, aVL, V5 and V6, S wave
amplitude in leads III, aVL, V1, V2, V3.
Based on the measures we used in our study
selected ECG criteria for LVH detection in cases
with LBBB: QRS > 160 ms, SV1 ≥ 30 mm, R V5 or
V6 > 25 mm, SV1+RV5 or V6 ≥ 45 mm, Cornell
index RaVL+SV3 > 20 mm (women), 28 mm (men),
RaVL ≥ 7.5 mm, RI+SIII ≥ 25 mm and presence of
left atrial enlargement — P wave duration in II
> 110 ms and/or P terminal force in V1 ≥ 0.04 mV/s.
CMRI and left ventricular mass measurement
Cardiac magnetic resonance was performed
with the use of a 1.5 Tesla scaner (Magnetom Avan-
to, Siemens, Erlangen, Germany). Scout images
followed by 2-chamber and 4-chamber long-axis
images of the LV with the use of a steady state free
precession were obtained to find the final short axis
imaging planes. Short-axis images were registered
from the mitral valve insertion points to apex with
8 to 10 slices to encompass the entire LV. The im-
aging parameters were as follows: repetition time
of 30 ms, echo time of 1.15 ms, flip angle of 80°, ma-
trix of 156 × 192, field of view 276 × 340 mm, slice
thickness of 8 mm with slice gap of 1.6 mm and tem-
poral resolution < 30 ms. Images were analyzed
using dedicated software (MASS, Medis, Leiden,
Netherlands). Initially, short axis images were pre-
viewed from base to apex in a cinematic mode, then
endocardial and epicardial contours for end-diasto-
le and end-systole were manually traced and semi-
automatically propagated to other frames with sub-
sequent manual adjustments. Delineated contours
were used for the quantification of LV mass and
LVMI (LV mass/body surface area). LVH was de-
fined as LVMI exceeding reference values for sex
and age in normal population [3].
Statistical analysis
Continuous variables were reported as the
mean ± standard deviation, categorical variables
were expressed as frequency. We used standard
unpaired Student t test to compare continuous vari-
ables and Pearson X2 test for the comparison of
categorical values. Correlations between LVMI and
ECG parameters were analyzed using Pearson cor-
relation test. Sensitivity, specificity and overall ac-
curacy of selected ECG criteria were calculated. Re-
ceiver operating characteristic (ROC) analysis was
also computed to verify diagnostic value of ECG-
-LVH criteria in relation to CMRI diagnosis. Besides
basically implemented ECG-LVH criteria we select-
ed ECG variables of the highest statistical value to
compute a combinations to achieve optimal sensi-
tivity and specificity. A p value below 0.05 was con-
sidered statistically significant. For the statistical
analysis we used SPSS software v. 8.0.
Results
Mean QRS duration was 164 (134–220) ms, in
34/36 patients QRS was ≥ 140 ms.
Comparison of patients with and without
LVH in CMRI
According to the CMRI criteria LVH was diag-
nosed in 17 (47%) patients (6 women and 11 men).
In Table 1 we present the comparison of ECG pa-
rameters in two groups — with and without LVH.
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The most prominent differences were observed in
the amplitude of S waves in V2 and V3. Only in V6
the R wave amplitude was significantly higher in
LVH group. Finally we analyzed three additional
parameters based on the amplitude of R and/or
S waves — S2+S3, SV2+RV5 or V6, SV2 or
SV3 + RV5 or RV6.
Correlations of LVMI and ECG parameters
We correlated LVMI with ECG parameters
with following results — QRS: r = 0.2 (NS), P wave
duration: r = 0.47 (p = 0.005), RI: r = 0.42 (p = 0.01),
SIII: r = 0.27 (NS), SV1: r = 0.53 (p = 0.001), SV2:
r = 0.31 (NS), SV3: r = 0.42 (p = 0.01), RV5: r = 0.5
(p = 0.002), RV6: r = 0.61 (p = 0.0001), RI+SIII:
r = 0.37 (NS), SV1+RV5, 6: r = 0.64 (p = 0.001),
RaVL+SV3: r = 0.5 (p = 0.002). Correlations with
additional parameters were as follows: SV2+SV3:
r = 0.42 (p = 0.01), SV2+RV5, 6: r = 0.71 (p = 0.0001),
SV2, 3+RV5, 6: r = 0.75 (p = 0.0001) (Fig. 1).
Predictive value of ECG for LVH in LBBB
Results of the ROC analysis are shown in
Table 2. The highest values (area under curve > 0.8)
were noted for parameters that included S wave
amplitude: S in V2, V3 i.e. RaVL+SV3, SV2+SV3,
Table 1. Comparison of ECG parameters between two groups with and without left ventricular hyper-
trophy (LVH) detected in cardiac magnetic resonance imaging.
Parameter All patients LVH+ (n = 17) LVH– (n = 19) P
Age [years] 57 ± 12 (33–80) 56 ± 14 58 ± 11 NS
Women/men 15/21 6/11 9/10 NS
LVMI [g/m2] 87 ± 27 (42–166) 108 ± 22 67 ± 14 0.0001
QRS [ms] 164 ± 21 (134–220) 170 ± 25 158 ± 14 NS
P wave [ms] 112 ± 20 (72–147) 119 ± 23 106 ± 15 0.05
LA enlargement 10/34 (2 pts AF) 9/17(53%) 1/17(6%) 0.003
R in I [mm] 7.7 ± 4.2 (1–20) 8.4 ± 5.2 7.1 ± 3.1 NS
S in III [mm] 8.6 ± 6.7 (0–38) 9 ± 8.9 8.2 ± 4.1 NS
R in aVL [mm] 7.9 ± 5.7 (2–35) 8.5 ± 7.7 7.3 ± 2.9 NS
S in V1 [mm] 19.4 ± 9.4 (5–54) 23.2 ± 10.9 16 ± 6.2 0.02
S in V2 [mm] 27.4 ± 10.1 (11–51) 33.6 ± 8.4 21.8 ± 8.1 0.0001
S in V3 [mm] 27.6 ± 11.7 (6–50) 34.6 ± 10.3 21.3 ± 9.2 0.0001
R in V5 [mm] 9.6 ± 12.3 (0–50) 11.2 ± 13.7 8 ± 11 NS
R in V6 [mm] 12.1 ± 10.7 (3–50) 15 ± 11.7 9.4 ± 9.2 0.02
RI+SIII [mm] 16.3 ± 9.7 (4–58) 17.4 ± 12.9 15.4 ± 5.9 NS
RaVL+SV3 [mm] 35 ± 12 (15–55) 43 ± 10 28.6 ± 9.4 0.0001
SV1+RV5, 6 [mm] 31 ± 19 (10–104) 37 ± 23 26 ± 12 NS
SV2+SV3 [mm] 55 ± 19 (17–95) 68 ± 15 43 ± 14 0.0001
SV2+RV5, 6 [mm] 40.2 ± 16.4 (16–89) 49.3 ± 15.2 31.9 ± 12.9 0.001
SV2, 3+RV5, 6 [mm] 44.4 ± 15.9 (16–89) 54.4 ± 12.7 35.5 ± 13.1 0.0001
LVMI — left ventricular mass index; LA — left atrial; AF — atrial fibrillation
Figure 1. Correlation between left ventricular mass in-
dex (LVMI) and maximal sum of amplitude of S wave in
V2 or V3 and R wave in V5 or V6; LVH — left ventricular
hypertrophy.
0 20 40 60 80
LVH+
LVH–
100
SV2, 3 + RV5, 6 [mm]
r = 0.75 (p = 0.0001)
LV
M
I [
g/
m
 ]2
0
20
40
60
80
100
120
140
160
180
594
Cardiology Journal 2012, Vol. 19, No. 6
www.cardiologyjournal.org
autopsy or echocardiographic study [7–14]. The
most frequently cited ECG criterion for LVH in
patients with LBBB (S in V2+RV6 > 45 mm) was
reported with maximal 86% sensitivity and 100%
specificity [15].
Now the results of CMRI are more accurate and
reproducible in LV mass quantification. CMRI is
also used to determine the reason of LVH [16]. In
some studies data from CMRI was compared with
ECG measurements, to our knowledge there was
no study that did it for patients with LBBB.
Our study presented that in patients with
LBBB and CMRI defined LVH the most prominent
differences in ECG parameters between LVH+ and
LVH– groups were observed in S wave amplitude
in V2 and V3 and in the parameters that used S wave
amplitude (V2 and/or V3). The highest correlation
coefficients for ECG parameters and LVMI were
observed for combination of the amplitude of
S waves measured in V2 or V3 and R waves ampli-
tude measured in V5 or V6 — r = 0.71 and r = 0.75.
In one study that correlated LVMI calculated with
CMRI and ECG parameters in the group of patients
with aortic stenosis, correlation coefficients be-
tween ECG criteria and LVMI were comparable to
those in our LBBB group: Cornel index: 0.47
(LBBB: r = 0.5), SV1+RV5, 6: 0.57 (LBBB: r =
= 0.64), RI+SIII: 0.33 (LBBB: r = 0.37) [16]. How-
ever in the ROC analysis the results were slightly
different (Table 4).
In the Table 4 we compared the results of ROC
analysis, sensitivity and specificity of the parame-
ters that were used in three ECG/CMRI studies [17,
18]. The compared populations and cut-off ECG
points were different (general multiethnic popula-
tion in MESA study, aortic valve disease patients
in the second and our LBBB group). LBBB patients
SV2+RV5 or V6, SV2 or V3+RV5 or V6. Based on
the ROC analysis we proposed the new cut-off val-
ues for: Cornell index (37 mm), SV2+SV3 (60 mm),
SV2+RV5 or V6 (40 mm) and SV2 or V3 + RV5 or
V6 (40 mm). In Table 3 we present the sensitivity,
specificity and overall accuracy of the ECG criteria for
LVH detection in presence of LBBB. The highest
clinical value was observed for the ECG parameters
that included S wave amplitude in V2 and/or V3.
Discussion
It is well known that patients with LBBB have
more frequently hypertrophied LV than those with
QRS without intraventricular conduction abnorma-
lities [8]. Several studies correlated ECG LVH pa-
rameters in patients with LBBB with the results of
Table 2. ROC — analysis for ECG-left ventricular
hypertrophy criteria.
Parameter Area under curve P
QRS duration 0.635 NS
P wave duration 0.687 NS
R aVL 0.497 NS
SV1 0.711 0.03
SV2 0.848 0.0001
SV3 0.837 0.0001
RaVL+SV3 0.875 0.0001
RV6 0.728 0.02
R I+SIII 0.491 NS
SV1+RV5, 6 0.655 NS
SV2+SV3 0.882 0.0001
SV2+RV5, 6 0.856 0.0001
SV2, 3+RV5, 6 0.861 0.0001
Table 3. Sensitivity, specificity and overall accuracy of selected ECG parameters in left ventricular
hypertrophy diagnosis.
Parameter Sensitivity Specificity Overall accuracy
QRS > 160 ms 65% 58% 61%
Left atrial enlargement 53% 94% 74%
RaVL ≥ 7.5 mm 47% 57% 53%
RI+SIII ≥ 25 mm 18% 95% 58%
S in V1 ≥ 30 mm 18% 95% 58%
R V5or RV6 > 25 mm 12% 95% 55%
SV1+RV5, 6 > 35 mm 35% 79% 58%
SV2+SV3 > 60 mm 88% 89% 89%
SV2+RV5, 6 ≥ 40 mm 76% 79% 78%
SV2, 3+RV5, 6 > 40 mm 94% 79% 86%
RaVL+SV3 > 37 mm 88% 89% 89%
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were excluded in the aortic valve study; there is no
data about LBBB patients in MESA study. The best
ECG results in the prediction of LVH were record-
ed in our small LBBB study. We know that such
small number of analyzed cases decreased the va-
lue of our results but our findings were achieved
with recalibrated parameters. It is not a new con-
ception. The necessity of recalibration ECG LVH
criteria (CMRI as a reference) in patients with QRS
< 120 ms was postulated by Alfakih et al. [19]. They
proposed new cut-off values for Sokolov and Cor-
nell indexes separately for male and female patients.
It should be also pointed that the frequency of the
presence of the LVH in analyzed population may be
an important factor that determines the sensitivi-
ty/specificity results. LVH is much more frequent-
ly observed in patients with LBBB. Havelda et al.
[13] in their study from 1982 observed higher ac-
curacy of the ECG for LVH detection in patients
with more pronounced LVH. Opposite observation
reported Kafka et al. [14] in 1985 in echocardio-
graphy/ECG study of 100 patients with LBBB. The
sensitivity and specificity was lower in cases with
LVMI > 215 g/m2 than in those with LVMI
> 115 g/m2. LVH ECG parameters were also verified
with computer tomography in the study conducted by
Truong et al. [20]. The Cornel and Sokolov index
achieved 22% and 35% sensitivity and 97% and 90%
specificity. The authors did not postulate the ne-
cessity of recalibration. LVH ECG parameters were
also correlated with the autopsy results. Zmyslins-
ki et al. [11] correlated LV mass with selected ECG
parameters. The maximum value for correlation
coefficient achieved 0.375 for R wave amplitude in
aVL and 0.373 for SV1 or SV2+RV5 or RV6. In our
study we used LVMI and r values were much high-
er — up 0.75. These values were lower for non-in-
dexed LV mass. What is interesting, the mean heart
weight of patients with complete LBBB in this study
was similar to mean LV mass in our study. The an-
alyzed populations in those 2 studies are different
and cannot be simply compared. Peterson and Tikoff
[10] in their clinical-pathologic study of 50 patients
with LBBB postulated that LVH could not be pre-
dicted with ECG criteria. However as authors com-
mented the association of LVH and LBBB was prob-
ably less pronounced in living patients. In 1984
Klein et al. [15] based on the echocardiographic
verification proposed the following parameter —
sum of the S amplitude in V2 and R wave amplitude
in V6 above 45 mm. The reported sensitivity
achieved 86%, specificity 100%. Additionally LVH
diagnosis was supported by the presence of left atri-
al enlargement and QRS duration > 160 ms. Impor-
tant value of the presence of the left atrial enlarge-
ment in LVH detection was also reported in our
study. Kafka et al. [14] in echocardiography/ECG
study reported comparable results in 100 patients
with LBBB. In our study the highest accuracy for
LVH detection in LBBB ECG was achieved when
the combination of the amplitude of S waves in V2–
–V3 and R waves in aVL or V5, V6. Similar observa-
tion reported Zmyslinski et al. [11] however it was
defined as maximal sum of R and S wave in any pre-
cordial lead.
ECG is not a perfect tool in the LV mass esti-
mation and definition of presence/absence of the
LVH. However ECG presents information on the
cardioelectric field in hypertrophied hearts and this
information (as it is pointed by Bacharova [21]) is
an added value of ECG. This can possibly have im-
portant impact on the value of ECG as a predictor
of cardiac events.
Additional comment is necessary to our results
of patients with hypertrophic cardiomyopathy.
There were 4 of them with LBBB and QRS dura-
tion/LVMI as follows: 170 ms/104 g/m2, 190 ms/
/166 g/m2, 156 ms/53 g/m2 (no LVH criteria in CMRI),
140 ms/143 g/m2. Generally in our group and in hy-
pertrophic cardiomyopathy patients there was no
relation between QRS duration and LV mass in
CMRI. The cases with hypertrophic cardiomyopa-
thy were selected for the study based of previously
declared LBBB criteria. On the Figure 2 there is
an example of ECG of the first reported case with
hypertrophic cardiomyopathy.
Table 4. Comparison of ROC analysis, sensitivity and specificity of selected parameters in three cardiac
magnetic resonance imaging studies.
MESA study Aortic valve disease Our study
(n = 4967) (n = 120)
ROC Sensitivity Specificity ROC Sensitivity Specificity ROC Sensitivity Specificity
RaVL+SV3 0.56 15.1% 97.3% 0.78 52% 87% 0.87 88% 89%
SV1+RV5, V6 0.59 26.0% 92.6% 0.86 52% 87% 0.65 35% 79%
MESA and aortic valve disease study used the following cut-points: for RaVL+SV3 > 2.8 mV in men and > 2.0 mV in women; for SV1+RV5, V6 ≥ 3.5 mV
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Limitations of the study
Our study has limitations that merit discussion.
The most important limitation is the small number
of patients included in this study. Our population is
inhomogeneous. We did not analyze consecutive
patients with LBBB, we analyzed only those that had
CMRI. Therefore our population is probably not ful-
ly typical with clinical profile of patients with LBBB.
As we could observe in literature the number of pa-
tients with LBBB analyzed in previous studies was
higher but none of them used CMRI as a reference
for LVH detection. We also could not analyze the
gender and race differences. We were unable to ve-
rify proposed criteria using new set of patients.
The assessment of LV measurements by MRI
has limitations. In general they are related to the
partial volume effects and the problem whether or
not include the most basal slice of the MRI into the
measurements of LV volumes. This can results in
± 10% variations in measured volumes.
Conclusions
In patients with LBBB the ECG parameters
based on the amplitude of S wave in V2 or V3 and
R wave in the leads aVL, V5, V6 have the highest
clinical value in the prediction of the LVH determined
by CMRI. It was necessary to recalibrate these pa-
rameters and it is needed to verify them in larger
number of LBBB patients.
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